Works matching AU Sugawara, Shunichi

Results: 67
    1

    Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.

    Published in:
    2017
    By:
    • Shinjiro Sakamoto;
    • Teppei Yamada;
    • Yasuhiro Terazaki;
    • Koichi Yoshiyama;
    • Shunichi Sugawara;
    • Shinzo Takamori;
    • Satoko Matsueda;
    • Shigeki Shichijo;
    • Akira Yamada;
    • Masanori Noguchi;
    • Kyogo Itoh;
    • Noboru Hattori;
    • Nobuoki Kohno;
    • Tetsuro Sasada;
    • Sakamoto, Shinjiro;
    • Yamada, Teppei;
    • Terazaki, Yasuhiro;
    • Yoshiyama, Koichi;
    • Sugawara, Shunichi;
    • Takamori, Shinzo
    Publication type:
    journal article
    2
    3

    A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 1, p. 85, doi. 10.1016/j.cllc.2023.09.006
    By:
    • Shinji Nakamichi;
    • Kaoru Kubota;
    • Kotone Matsuyama;
    • Toshihiro Misumi;
    • Toshiyuki Kozuki;
    • Shunichi Sugawara;
    • Katsuhiko Naoki;
    • Nobuaki Kobayashi;
    • Takehito Shukuya;
    • Tsuneo Shimokawa;
    • Masashi Ishihara;
    • Hiroshi Wakui;
    • Yukio Hosomi;
    • Hiroshi Tanaka;
    • Haruhiro Saito;
    • Shinobu Hosokawa;
    • Yuichi Takiguchi;
    • Takashi Kasai;
    • Hiroshi Nokihara;
    • Ryo Morita
    Publication type:
    Article
    4

    A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non--Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 4, p. 371, doi. 10.1016/j.cllc.2023.01.008
    By:
    • Akihiko Miyanaga;
    • Hajime Asahina;
    • Satoshi Watanabe;
    • Takehito Shukuya;
    • Yukari Tsubata;
    • Yukio Hosomi;
    • Shunichi Sugawara;
    • Makoto Maemondo;
    • Tetsuya Okano;
    • Satoshi Morita;
    • Kotone Matsuyama;
    • Kunihiko Kobayashi;
    • Masahiro Seike
    Publication type:
    Article
    5

    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2020
    By:
    • Shiraishi, Yoshimasa;
    • Kishimoto, Junji;
    • Tanaka, Kentaro;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirano, Katsuya;
    • Azuma, Koichi;
    • Hataji, Osamu;
    • Hayashi, Hidetoshi;
    • Tachihara, Motoko;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Okamoto, Isamu
    Publication type:
    journal article
    6
    7
    8
    9

    Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

    Published in:
    2020
    By:
    • Naqash, Abdul Rafeh;
    • Ricciuti, Biagio;
    • Owen, Dwight H.;
    • Florou, Vaia;
    • Toi, Yukihiro;
    • Cherry, Cynthia;
    • Hafiz, Maida;
    • De Giglio, Andrea;
    • Muzaffar, Mavish;
    • Patel, Sandip H.;
    • Sugawara, Shunichi;
    • Burkart, Jarred;
    • Park, Wungki;
    • Chiari, Rita;
    • Sugisaka, Jun;
    • Otterson, Gregory A.;
    • de Lima Lopes, Gilberto;
    • Walker, Paul R.
    Publication type:
    Correction Notice
    10

    Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5
    By:
    • Naqash, Abdul Rafeh;
    • Ricciuti, Biagio;
    • Owen, Dwight H.;
    • Florou, Vaia;
    • Toi, Yukihiro;
    • Cherry, Cynthia;
    • Hafiz, Maida;
    • De Giglio, Andrea;
    • Muzaffar, Mavish;
    • Patel, Sandip H.;
    • Sugawara, Shunichi;
    • Burkart, Jarred;
    • Park, Wungki;
    • Chiari, Rita;
    • Sugisaka, Jun;
    • Otterson, Gregory A.;
    • de Lima Lopes, Gilberto;
    • Walker, Paul R.
    Publication type:
    Article
    11

    Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).

    Published in:
    Oncology & Therapy, 2022, v. 10, n. 1, p. 253, doi. 10.1007/s40487-022-00188-2
    By:
    • Hata, Akito;
    • Shiraishi, Yoshimasa;
    • Inui, Naoki;
    • Okada, Morihito;
    • Morise, Masahiro;
    • Akiyoshi, Kohei;
    • Takeda, Masayuki;
    • Watanabe, Yasutaka;
    • Sugawara, Shunichi;
    • Shinagawa, Naofumi;
    • Kubota, Kaoru;
    • Saeki, Toshiaki;
    • Tamura, Tomohide
    Publication type:
    Article
    12
    13
    14

    Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

    Published in:
    2016
    By:
    • Takeda, Masayuki;
    • Yamanaka, Takeharu;
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Azuma, Koichi;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirashima, Tomonori;
    • Yonesaka, Kimio;
    • Urata, Yoshiko;
    • Murakami, Haruyasu;
    • Saito, Haruhiro;
    • Kubo, Akihito;
    • Sawa, Toshiyuki;
    • Miyahara, Eiji;
    • Nogami, Naoyuki;
    • Nakagawa, Kazuhiko;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    journal article
    15

    Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816.

    Published in:
    Cancer Science, 2024, v. 115, n. 2, p. 540, doi. 10.1111/cas.16030
    By:
    • Mitsudomi, Tetsuya;
    • Ito, Hiroyuki;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Shio, Yutaka;
    • Tomii, Keisuke;
    • Okami, Jiro;
    • Sakakura, Noriaki;
    • Kubota, Kaoru;
    • Takamochi, Kazuya;
    • Atagi, Shinji;
    • Tsuboi, Masahiro;
    • Oizumi, Satoshi;
    • Ikeda, Norihiko;
    • Ohde, Yasuhisa;
    • Ntambwe, Ives;
    • Mahmood, Javed;
    • Cai, Junliang;
    • Tanaka, Fumihiro
    Publication type:
    Article
    16

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    17
    18

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    19
    20

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    21

    ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651
    By:
    • Azuma, Koichi;
    • Nishio, Makoto;
    • Hayashi, Hidetoshi;
    • Kiura, Katsuyuki;
    • Satouchi, Miyako;
    • Sugawara, Shunichi;
    • Hida, Toyoaki;
    • Iwamoto, Yasuo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Ikeda, Satoshi;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Asahina, Seitaro;
    • Komatsu, Kanji;
    • Morita, Satoshi;
    • Fukuoka, Masahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    22
    23

    Accumulation of p62/ SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma.

    Published in:
    Cancer Science, 2012, v. 103, n. 4, p. 760, doi. 10.1111/j.1349-7006.2012.02216.x
    By:
    • Inoue, Daisuke;
    • Suzuki, Takashi;
    • Mitsuishi, Yoichiro;
    • Miki, Yasuhiro;
    • Suzuki, Satoshi;
    • Sugawara, Shunichi;
    • Watanabe, Mika;
    • Sakurada, Akira;
    • Endo, Chiaki;
    • Uruno, Akira;
    • Sasano, Hironobu;
    • Nakagawa, Takayuki;
    • Satoh, Kennichi;
    • Tanaka, Nobuyuki;
    • Kubo, Hiroshi;
    • Motohashi, Hozumi;
    • Yamamoto, Masayuki
    Publication type:
    Article
    24
    25

    Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901.

    Published in:
    Cancers, 2025, v. 17, n. 9, p. 1551, doi. 10.3390/cancers17091551
    By:
    • Saito, Shin;
    • Kawashima, Yosuke;
    • Tanaka, Hisashi;
    • Yoshimura, Naruo;
    • Tsukita, Yoko;
    • Saito, Ryota;
    • Nakagawa, Taku;
    • Inomata, Minehiko;
    • Nagashima, Hiromi;
    • Sugawara, Shunichi
    Publication type:
    Article
    26
    27
    28
    29

    First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1354, doi. 10.1007/s10147-023-02390-2
    By:
    • Nishio, Makoto;
    • Ohe, Yuichiro;
    • Ikeda, Satoshi;
    • Yokoyama, Toshihide;
    • Hayashi, Hidetoshi;
    • Fukuhara, Tatsuro;
    • Sato, Yuki;
    • Tanaka, Hiroshi;
    • Hotta, Katsuyuki;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Kasahara, Kazuo;
    • Naito, Tateaki;
    • Li, Li;
    • Gupta, Ravi G.;
    • Bushong, Judith;
    • Mizutani, Hideaki
    Publication type:
    Article
    30
    31

    Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
    By:
    • Katakami, Nobuyuki;
    • Yokoyama, Toshihide;
    • Morita, Satoshi;
    • Okamoto, Tatsuro;
    • Urata, Yoshiko;
    • Hattori, Yoshihiro;
    • Iwamoto, Yasuo;
    • Sato, Yuki;
    • Ikeda, Norihiko;
    • Takahashi, Toshiaki;
    • Daga, Haruko;
    • Oguri, Tetsuya;
    • Fujisaka, Yasuhito;
    • Nishino, Kazumi;
    • Sugawara, Shunichi;
    • Kozuki, Toshiyuki;
    • Oki, Masahide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    32
    33

    Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
    By:
    • Sugawara, Shunichi;
    • Kondo, Masashi;
    • Yokoyama, Toshihide;
    • Kumagai, Toru;
    • Nishio, Makoto;
    • Goto, Koichi;
    • Nakagawa, Kazuhiko;
    • Seto, Takashi;
    • Yamamoto, Nobuyuki;
    • Kudou, Kentarou;
    • Asato, Takayuki;
    • Zhang, Pingkuan;
    • Ohe, Yuichiro
    Publication type:
    Article
    34

    Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 515, doi. 10.1007/s10147-020-01828-1
    By:
    • Kawashima, Yosuke;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Nakagawa, Taku;
    • Watanabe, Kana;
    • Morikawa, Naoto;
    • Takamura, Kei;
    • Kanazawa, Kenya;
    • Kuda, Tomoya;
    • Usui, Kazuhiro;
    • Sekine, Akimasa;
    • Inoue, Akira;
    • Sugawara, Shunichi
    Publication type:
    Article
    35

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
    By:
    • Sugawara, Shunichi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Nokihara, Hiroshi;
    • Ohe, Yuichiro;
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Goto, Koichi;
    • Maemondo, Makoto;
    • Ichinose, Yukito;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Gemma, Akihiko;
    • Imamura, Fumio;
    • Shingyoji, Masato;
    • Saka, Hideo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Okamoto, Isamu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    36
    37

    Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

    Published in:
    Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145
    By:
    • Minami, Soichiro;
    • Kawashima, Yosuke;
    • Munakata, Yasuhiko;
    • Matsuno, Masahiro;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    38

    Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase (ALK)‐positive lung cancer and multiple brain metastases.

    Published in:
    Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1981
    By:
    • Murakami, Yosuke;
    • Kawashima, Yosuke;
    • Chiba, Shinji;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    39
    40
    41

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    42

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    43
    44

    Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 352, doi. 10.1634/theoncologist.2013-0411
    By:
    • Maemondo, Makoto;
    • Inoue, Akira;
    • Sugawara, Shunichi;
    • Harada, Toshiyuki;
    • Minegishi, Yuji;
    • Usui, Kazuhiro;
    • Miwa, Koji;
    • Morikawa, Naoto;
    • Kambe, Mariko;
    • Ube, Kenji;
    • Watanabe, Kana;
    • Ishimoto, Osamu;
    • Sakakibara, Tomohiro;
    • Gemma, Akihiko;
    • Nukiwa, Toshihiro
    Publication type:
    Article
    45

    A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 439, doi. 10.1634/theoncologist.2012-0308
    By:
    • Harada, Toshiyuki;
    • Oizumi, Satoshi;
    • Ito, Kenichiro;
    • Takamura, Kei;
    • Kikuchi, Eiki;
    • Kuda, Tomoya;
    • Sugawara, Shunichi;
    • Suzuki, Aya;
    • Maemondo, Makoto;
    • Fujita, Yuka;
    • Kinoshita, Ichiro;
    • Inoue, Akira;
    • Hommura, Fumihiro;
    • Katsuura, Yutaka;
    • Dosaka‐Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    46

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    2012
    By:
    • Oizumi, Satoshi;
    • Kobayashi, Kunihiko;
    • Inoue, Akira;
    • Maemondo, Makoto;
    • Sugawara, Shunichi;
    • Yoshizawa, Hirohisa;
    • Isobe, Hiroshi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Okinaga, Shoji;
    • Kato, Terufumi;
    • Harada, Toshiyuki;
    • Gemma, Akihiko;
    • Saijo, Yasuo;
    • Yokomizo, Yuki;
    • Morita, Satoshi;
    • Hagiwara, Koichi;
    • Nukiwa, Toshihiro
    Publication type:
    Journal Article
    47

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    Oncologist, 2012, v. 17, n. 6, p. 863, doi. 10.1634/theoncologist.2011-0426
    By:
    • OIZUMI, SATOSHI;
    • KOBAYASHI, KUNIHIKO;
    • INOUE, AKIRA;
    • MAEMONDO, MAKOTO;
    • SUGAWARA, SHUNICHI;
    • YOSHIZAWA, HIROHISA;
    • ISOBE, HIROSHI;
    • HARADA, MASAO;
    • KINOSHITA, ICHIRO;
    • OKINAGA, SHOJI;
    • KATO, TERUFUMI;
    • HARADA, TOSHIYUKI;
    • GEMMA, AKIHIKO;
    • SAIJO, YASUO;
    • YOKOMIZO, YUKI;
    • MORITA, SATOSHI;
    • HAGIWARA, KOICHI;
    • NUKIWA, TOSHIHIRO
    Publication type:
    Article
    48

    First‐line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non‐squamous non‐small cell lung cancer: Updated survival analysis of the ONO‐4538‐52/TASUKI‐52 randomized controlled trial.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 16, p. 17061, doi. 10.1002/cam4.6348
    By:
    • Kim, Hye Ryun;
    • Sugawara, Shunichi;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Inui, Naoki;
    • Hida, Toyoaki;
    • Lee, Ki Hyeong;
    • Yoshida, Tatsuya;
    • Tanaka, Hiroshi;
    • Yang, Cheng‐Ta;
    • Nishio, Makoto;
    • Ohe, Yuichiro;
    • Tamura, Tomohide;
    • Yamamoto, Nobuyuki;
    • Yu, Chong‐Jen;
    • Akamatsu, Hiroaki;
    • Takahashi, Shigeru;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    49

    Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 8, p. 9133, doi. 10.1002/cam4.5652
    By:
    • Takeuchi, Susumu;
    • Kubota, Kaoru;
    • Sugawara, Shunichi;
    • Teramukai, Satoshi;
    • Noro, Rintaro;
    • Fujikawa, Kei;
    • Hirose, Takashi;
    • Atagi, Shinji;
    • Minami, Seigo;
    • Iida, Shinichiro;
    • Kuraishi, Hiroshi;
    • Aiba, Tomoiki;
    • Minegishi, Yuji;
    • Matsumoto, Masaru;
    • Seike, Masahiro;
    • Gemma, Akihiko;
    • Kawahara, Masaaki
    Publication type:
    Article
    50